eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de la bio-CDMO
30 mai 2023 16h06 HE
|
EUREKARE
eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de...
eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader
30 mai 2023 16h06 HE
|
EUREKARE
Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company’s unique offer...
Global Cell Harvesting Market Report 2023: Players Include PerkinElmer, Connectorate, Sartorius and Terumo
23 mai 2023 09h43 HE
|
Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Cell Harvesting Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers...
eureKING, le premier SPAC européen dans la santé dédié à la bioproduction, annonce son intention de se rapprocher de Skyepharma pour créer un nouveau leader européen de la bio-CDMO
16 mai 2023 11h45 HE
|
EUREKARE
Skyepharma, un CDMO (« Contract Development Manufacturing Organisation ») basé en France avec plus de 20 ans d'expertise en matière d'innovation et de développement, est un acteur reconnu dans les...
eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces its intention to combine with Skyepharma to build a new European bio-CDMO leader
16 mai 2023 11h45 HE
|
EUREKARE
Skyepharma, a France-based CDMO with over 20 years of innovation and development expertise, is a renowned player in the global biopharma and consumer health industries. The company’s unique offer in...
Dyadic to Participate at Two Industry Events in May
10 mai 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
26 avr. 2023 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Renewable Chemical Innovator Capra Biosciences to Build a Green Biochemical Production Facility in Manassas, Virginia
24 avr. 2023 09h00 HE
|
Capra Biosciences
MANASSAS, Va., April 24, 2023 (GLOBE NEWSWIRE) -- Capra Biosciences is scaling up their novel bioreactor technology to produce sustainable chemicals in Northern Virginia. This project was funded...
Cell and Gene Therapy Biomanufacturing Market, 2031
19 avr. 2023 06h03 HE
|
Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Biomanufacturing Market - A Global and Regional Analysis: Focus on Product Type, Application, Usage, End-user, and Region -...
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
12 avr. 2023 08h00 HE
|
Dyadic International, Inc.
JUPITER, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...